RAPT Therapeutics Reports First Quarter 2023 Financial Results Portfolio News / By Karina Tin May 11, 2023 RAPT Therapeutics Reports First Quarter 2023 Financial Results Read More »
Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update Portfolio News / By Karina Tin May 10, 2023 Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update Read More »
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates Portfolio News / By Karina Tin May 10, 2023 Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates Read More »
Kallyope Receives $8.2 Million Grant to Identify Novel Interventions for Children and Undernourished Pregnant Women and Mothers Experiencing Environmental Enteric Dysfunction Portfolio News / By Karina Tin May 10, 2023 Kallyope Receives $8.2 Million Grant to Identify Novel Interventions for Children and Undernourished Pregnant Women and Mothers Experiencing Environmental Enteric Dysfunction Read More »
eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update Portfolio News / By Karina Tin May 9, 2023 eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update Read More »
NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 Portfolio News / By Karina Tin May 8, 2023 NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 Read More »
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates Portfolio News / By Karina Tin May 8, 2023 ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates Read More »
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress Portfolio News / By Karina Tin May 8, 2023 Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress Read More »
NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data Portfolio News / By Karina Tin May 4, 2023 NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data Read More »
Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting Portfolio News / By Karina Tin May 3, 2023 Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting Read More »
